Get the Stockscreener App
67.84
3.58%
-2.52
Grail Inc stock is traded at $67.84, with a volume of 350.43K.
It is down -3.58% in the last 24 hours and up +5.05% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$70.36
Open:
$72.11
24h Volume:
350.43K
Relative Volume:
0.53
Market Cap:
$2.91B
Revenue:
$156.12M
Net Income/Loss:
$-395.33M
P/E Ratio:
-6.5383
EPS:
-10.3758
Net Cash Flow:
$-292.33M
1W Performance:
-6.58%
1M Performance:
+5.05%
6M Performance:
-35.33%
1Y Performance:
+70.80%
1-Day Range:
$67.47
$72.11
1-Week Range:
$67.47
$73.53
52-Week Range:
$29.95
$118.84
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
67.84 | 2.91B | 156.12M | -395.33M | -292.33M | -10.38 |
TMO
Thermo Fisher Scientific Inc
|
568.26 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
191.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
544.32 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
138.57 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.99 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Initiated | Mizuho | Neutral |
| Mar-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | TD Cowen | Hold |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-12-25 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
View All
Grail Inc Stock (GRAL) Latest News
Grail Inc (GRAL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Grail Inc (GRAL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Grail Inc (GRAL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Grail Inc (GRAL) Institutional Confidence - TradingKey
Grail Inc (GRAL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Grail Inc (GRAL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GRAL|Grail Inc|Price:67.760|Chg%:-2.600 - TradingKey
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Grail Class Action Lawsuit - PR Newswire
GRAL Shareholder Alert: GRAIL, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - lincolnjournal.com
Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail - MedCity News
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline - PR Newswire
$GRAL Fraud Notification: GRAIL, Inc. Sued for Fraud Over - GlobeNewswire
How Grail Inc Com (GRAL) Affects Rotational Strategy Timing - Stock Traders Daily
GRAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds - The National Law Review
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
GRAL FINAL DEADLINE: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages GRAIL, Inc. Investors to ... - Caledonian Record
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Lost Money on Grail, Inc. (GRAL)? Join Class Action Suit Seeking RecoveryContact SueWallSt - TradingView
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Grail Inc (GRAL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Grail investors face August 4 deadline in NHS-Galleri fraud class action - scanx.trade
Priority Health to Offer Multi-cancer Early Detection Blood Test to Employer Plans - DBusiness Magazine
GRAL Deadline Alert: Levi & Korsinsky Reminds Grail, Inc. (GRAL) Investors of Securities Class Action Deadline on August 4, 2026 - PR Newswire
GRAIL, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 4, 2026 - GlobeNewswire
Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone - Stocktwits
GRAL INVESTOR ALERT: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS - Sahm
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman - Morningstar
GRAL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
DEADLINE ALERT for BMI, PICS, VRRM, and GRAL: The Law - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors - lincolnjournal.com
GRAL Deadline Alert: The Gross Law Firm Reminds GRAIL, Inc. (GRAL) Investors of Securities Class Action Deadline on August 4, 2026 - Morningstar
Enterprise value to EBIT forward of GRAIL, Inc. – NASDAQ:GRAL - TradingView
Bragar Eagel & Squire, P.C. Reminds GRAIL, Inc. Investors - GlobeNewswire
Deadline Alert: Grail, Inc. (GRAL) Shareholders Who Lost - GlobeNewswire
GRAL Shareholder Alert: Grail, Inc. Securities Class Action LawsuitInvestors Should Contact Levi & Korsinsky - GlobeNewswire
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS - GlobeNewswire
GRAL GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitRGRD Law - marketscreener.com
GRAIL, Inc. Deadline: GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit - The Conway Daily Sun
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Badger Meter, Inc. (BMI), Grail, Inc. (GRAL), and Verra Mobility Corporation (VRRM) Announced by Holzer & Holzer, LLC - The Malone Telegram
GRAIL, INC. DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
GRAL INVESTOR DEADLINE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
ROSEN, THE FIRST FILING FIRM, Encourages Zillow Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BitGo Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
GRAL Shareholder Alert: August 4, 2026 Lead Plaintiff - GlobeNewswire
GRAL Legal Deadline Notice: Important GRAIL, Inc. Deadline - GlobeNewswire
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GRAIL, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Priority Health partners with GRAIL for cancer test coverage By Investing.com - Investing.com South Africa
Priority Health partners with GRAIL for cancer test coverage - Investing.com
GRAIL, Inc. (GRAL) director receives 276 deferred stock units as fees - Stock Titan
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.02%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):